stella
beta
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia — Stella
Recruiting
Back to Relapsed/Refractory Acute Myeloid Leukemia trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Shanghai Children's Medical Center, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov